Seek Returns

JNJ vs. ORCL: Johnson & Johnson vs. Oracle Stock Comparison

How do Johnson & Johnson (JNJ) and Oracle (ORCL) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Johnson & Johnson (JNJ) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Oracle (ORCL) belongs to Information Technology (Software & Services) — their GICS classifications point to very different parts of the market.

Company profile comparison for Johnson & Johnson (JNJ) and Oracle (ORCL)
Profile ItemJNJORCL
NameJohnson & JohnsonOracle Corporation
Country/RegionUnited StatesUnited States
GICS SectorHealth CareInformation Technology
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesSoftware & Services
GICS IndustryPharmaceuticalsSoftware
GICS Sub-IndustryPharmaceuticalsSystems Software
Market Capitalization664.95 billion USD361.97 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateJanuary 2, 1962March 12, 1986
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

JNJ
ORCL
GSPC
Loading price history…
Johnson & Johnson (JNJ) vs. Oracle (ORCL), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Johnson & Johnson (JNJ) and Oracle (ORCL). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Johnson & Johnson (JNJ) and Oracle (ORCL). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Johnson & Johnson (JNJ) and Oracle (ORCL)
MetricJNJORCL
Total Return (1Y)53.82%-49.72%
Total Return (3Y, Annualized)27.51%3.11%
Total Return (5Y, Annualized)14.71%6.07%

Risk Profile

Drawdown History

JNJ
ORCL
GSPC
Loading price history…
Johnson & Johnson (JNJ) vs. Oracle (ORCL), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Johnson & Johnson (JNJ) and Oracle (ORCL). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Oracle (ORCL) has an aggressive beta of 1.80, indicating higher sensitivity to broad-market moves, while Johnson & Johnson (JNJ) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for Johnson & Johnson (JNJ) and Oracle (ORCL)
MetricJNJORCL
Volatility (1Y, Annualized)21.23%59.45%
Beta (5Y)0.211.80
Max Drawdown (5Y)-18.41%-64.58%
Avg. Volume (3M)6.93M33.24M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
JNJ and ORCL are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Johnson & Johnson (JNJ) and Oracle (ORCL)
MetricJNJORCL
Sharpe Ratio (1Y)2.33-0.91
Sortino Ratio (1Y)3.66-1.29

Profitability

ROE (TTM)

Both Johnson & Johnson (JNJ) at 20.02% and Oracle (ORCL) at 41.19% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.02%

Max
109.18%
JNJ
20.02%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

ORCL

Software & Services industry group

41.19%

Max
53.85%
ORCL
41.19%
Q3
17.90%
Median
6.59%
Q1
-9.59%
Min
-50.52%
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their ROE against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Net Margin (TTM)

For every dollar of sales, both Johnson & Johnson (JNJ) at 16.20% and Oracle (ORCL) at 26.36% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

16.20%

Max
18.05%
JNJ
16.20%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

ORCL

Software & Services industry group

26.36%

Max
41.17%
ORCL
26.36%
Q3
15.28%
Median
4.63%
Q1
-5.42%
Min
-33.17%
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Operating Margin (TTM)

Both Johnson & Johnson (JNJ) at 25.74% and Oracle (ORCL) at 35.63% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.74%

Max
83.12%
JNJ
25.74%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

ORCL

Software & Services industry group

35.63%

Max
46.89%
ORCL
35.63%
Q3
17.64%
Median
8.73%
Q1
-2.13%
Min
-30.45%
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Profitability Metrics

Profitability metrics for Johnson & Johnson (JNJ) and Oracle (ORCL)
MetricJNJORCL
ROE (TTM)20.02%41.19%
ROA (TTM)8.46%6.36%
Net Margin (TTM)16.20%26.36%
Operating Margin (TTM)25.74%35.63%
Gross Margin (TTM)67.78%63.96%

Growth

Revenue Growth

Both Johnson & Johnson (JNJ) at 6.05% and Oracle (ORCL) at 17.35% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their Revenue Growth across different time periods.

EPS Growth

Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while Oracle (ORCL) at 34.33% is closer to the peer norm — faster per-share earnings growth for JNJ.

Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Johnson & Johnson (JNJ) and Oracle (ORCL)
MetricJNJORCL
Revenue Growth (YoY)6.05%17.35%
Revenue Growth (3Y CAGR)5.60%10.48%
EPS Growth (YoY)90.50%34.33%
EPS Growth (3Y CAGR)17.90%23.84%

Financial Strength

Current Ratio (MRQ)

Oracle (ORCL) at 1.17 keeps current ratio within its industry’s typical mid-range, while Johnson & Johnson (JNJ) at 1.02 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for JNJ.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.02

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
JNJ
1.02
Min
0.10

ORCL

Software & Services industry group

1.17

Max
5.11
Q3
2.77
Median
1.67
ORCL
1.17
Q1
1.01
Min
0.03
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Debt / Equity (MRQ)

Johnson & Johnson (JNJ) at 0.55 carries an industry-typical debt-to-equity mix, while Oracle (ORCL) at 2.52 uses more debt funding than most peers.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.55

Max
1.42
Q3
0.65
JNJ
0.55
Median
0.15
Q1
0.02
Min
0.00

ORCL

Software & Services industry group

2.52

ORCL
2.52
Max
2.52
Q3
1.13
Median
0.40
Q1
0.07
Min
0.00
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their debt-to-equity ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Financial Strength Metrics

Financial strength metrics for Johnson & Johnson (JNJ) and Oracle (ORCL)
MetricJNJORCL
Current Ratio (MRQ)1.021.17
Debt / Equity (MRQ)0.552.52
Net Debt / EBITDA0.793.84

Dividends

Dividend Yield (TTM)

Both Johnson & Johnson (JNJ) at 1.94% and Oracle (ORCL) at 1.74% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.94%

JNJ
1.94%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ORCL

Software & Services industry group

1.74%

ORCL
1.74%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Dividend Payout Ratio (TTM)

Both Johnson & Johnson (JNJ) at 80.12% and Oracle (ORCL) at 31.35% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

80.12%

JNJ
80.12%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ORCL

Software & Services industry group

31.35%

ORCL
31.35%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Dividend Metrics

Dividend metrics for Johnson & Johnson (JNJ) and Oracle (ORCL)
MetricJNJORCL
Dividend Yield (TTM)1.94%1.74%
Dividend Payout Ratio (TTM)80.12%31.35%

Valuation

P/E Ratio (TTM)

Oracle (ORCL) at 18.20 sits in the cheaper P/E ratio quartile, while Johnson & Johnson (JNJ) at 41.92 is closer to its industry’s usual earnings multiple — a discount for ORCL, though growth and earnings durability still matter.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

41.92

Max
85.34
Q3
43.46
JNJ
41.92
Median
26.69
Q1
13.30
Min
0.07

ORCL

Software & Services industry group

18.20

Max
112.94
Q3
60.32
Median
32.91
Q1
18.77
ORCL
18.20
Min
6.69
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

P/S Ratio (TTM)

On P/S ratio, both Johnson & Johnson (JNJ) at 6.69 and Oracle (ORCL) at 5.04 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.69

Max
58.18
Q3
25.77
Median
7.30
JNJ
6.69
Q1
3.01
Min
0.01

ORCL

Software & Services industry group

5.04

Max
17.91
Q3
8.78
ORCL
5.04
Median
4.25
Q1
2.23
Min
0.02
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

P/B Ratio (MRQ)

Oracle (ORCL) at 5.68 is valued about in line with its industry on P/B ratio, while Johnson & Johnson (JNJ) at 8.16 carries an above-peer premium to book — JNJ is pricier on assets.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.16

Max
13.53
JNJ
8.16
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

ORCL

Software & Services industry group

5.68

Max
16.63
Q3
8.50
ORCL
5.68
Median
4.30
Q1
1.92
Min
-3.90
Loading chart…
Johnson & Johnson (JNJ) vs. Oracle (ORCL): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Valuation Metrics

Valuation metrics for Johnson & Johnson (JNJ) and Oracle (ORCL)
MetricJNJORCL
P/E Ratio (TTM)41.9218.20
P/S Ratio (TTM)6.695.04
P/B Ratio (MRQ)8.165.68
Free Cash Flow Yield (TTM)2.78%-12.67%